Here - The American Academy of Allergy Asthma and Immunology

134 Pages·2014·6.47 MB·English

THURSDAY, FEBRUARY 27 AND
FRIDAY, FEBRUARY 28
Thursday, February 27 3:45 Air Force
Kevin M. White, MD
Military Allergy Program 4:00 Army
0001 28th Annual Harold S. Nelson Military Allergy/ Michael R. Nelson, MD PhD FAAAAI
Immunology Symposium 4:15 Navy
Michael R. Kaplan, DO FAAAAI
7:20 am to 5:00 pm
4:30 Business Meeting and Award Presentations
Convention Center, Upper Level, Room 3
Pre-registration and ticket required. No fee for approved and Upon completion of this session, participants should be able to: Discuss the approach to
identifying allergic skin disorders in the military environment and the role of biopsy in the
registered military members. $60 fee for non-military members.
diagnosis and management; Identify the differential diagnosis of chronic urticaria and
Continental breakfast and box lunch included.
explain the diagnostic approach; Discuss the application of novel therapy in the treatment
Credit: 7.00 CME / 8.00 CE of chronic urticaria.
Moderator: Kimberly S. Johnson, MD
Fellows-In-Training and New Allergist/Immunologist
Kimberly S. Johnson, MD
8:00 Morning Address: Dermatology for the Military Allergist Assembly Joint Reception
Timothy Straight, MD PhD 7:00 to 8:00 pm
9:00 Break Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
Fellow Original Research Reception is open to current Chrysalis participants, FITs and NAIA
9:30 Safety of Cluster Allergen Immunotherapy During Refill Dosing members.
Tiffany J. Owens, MD
Friday, February 28
9:50 Demographics and Retention Patterns for 1999-2011 U.S. Air
Force Allergy Graduates Fellows-in-Training Program
Michelle Bandino, MD
1011 FIT Symposium
10:10 Serologic Specific IgE (sIgE) Testing in a Closed Healthcare
7:00 am to 2:00 pm
System
Marriott North Tower, Lobby Level, San Diego Ballroom Salon B
Daniel A. Steigelman, MD
Pre-registration and ticket required. No fee. Continental breakfast and
10:30 Safety and Efficacy of a 12-Week Maintenance Interval in Patients
box lunch included.
Treated With Imported Fire Ant Immunotherapy
Credit: No CME / No CE
Karla E. Adams, MD
7:00 Networking Breakfast
Staff Original Research
8:00 Introductions
10:50 Vitamin D Supplementation Improve Urticaria Symptoms in Adult
Chronic Urticaria Taylor A. Banks, MD
Tadech Boonpiyathad, MD Mary Beth Fasano, MD FAAAAI
11:10 Increased Respiratory Illness and Transient Immune Alterations 8:05 Networking Organizations
Seen with Multiple Vaccinations Administered in a Stressful 8:15 American Board of Allergy and Immunology
Environment Stephen I. Wasserman, MD FAAAAI
Rachel Umi Lee, MD FAAAAI 8:20 Allergy Immunotherapy: The Basics
11:30 Lunch and Bruton Lecture: Treatment Options for Refractory Michael R. Nelson, MD PhD FAAAAI
Urticaria 8:50 Immunotherapy Extracts
David A. Khan, MD FAAAAI Robert G. Hamilton, PhD D.ABMLI FAAAAI
Fellow Case Reports 9:20 Break
1:00 Selective IgM Deficiency Presenting as Cryptogenic Organizing 9:35 Welcome from the AAAAI President
Pneumonia Linda Cox, MD FAAAAI
Cory A. Lundberg, DO 9:45 Immunotherapy: New and Emerging Issues
1:20 A Devastating Outcome in Undiagnosed X-Linked Linda Cox, MD FAAAAI
Agammaglobulinemia: A Call for Earlier Screening 10:15 Immunomodulation with Immunotherapy
Karen Elizabeth Bruner, MD Joann C. Blessing-Moore, MD FAAAAI
1:40 Intractable Burkholderia Vietnamiensis and Hemophagocytic 10:45 Pearls and Pitfalls of Diagnostic Testing
Lymphohistiocytosis in Homozygous Interleukin-12 Receptor Michael S. Blaiss, MD FAAAAI
Beta-1 Deficiency 11:15 Venom Immunotherapy
Ki Lee Milligan, MD David B.K. Golden, MD FAAAAI
2:00 Break 11:45 Difficult AIT Cases
2:30 Vaccine Healthcare Center Update David A. Khan, MD FAAAAI
Limone C. Collins Jr., MD 12:15 Networking Lunch
3:00 Military Aeroallergen Extract Laboratory Updates 1:00 AIT Prescription Workshop
Susan E. Kosisky, BS MHA Upon completion of this session, participants should be able to: Describe the pathophysi-
Consultants to the Surgeons General Updates: ology, initial evaluation and management of patients with allergies to aeroallergens and/or
3:30 VHA Allergy Committee venoms; Identify recent advances in the field of immunotherapy, including mechanisms of
immunomodulation; Discuss current and emerging treatment modalities and adjuncts in
Joseph S. Yusin, MD FAAAAI
the management of aeroallergen and venom allergic patients.
25
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Allied Health Course 1101D Differentiating Asthma From COPD: Why is This
So Hard?
1101 Advanced Practice Course
Marriott North Tower, Lobby Level, Atlanta & Chicago
8:00 am to 12:30 pm
Edward O. Corazalla, MS RPFT
Marriott North Tower, Lobby Level, Marriott Hall Salons 1 & 2
Karen L. Gregory, DNP APRN-BC RRT AE-C
Pre-registration and ticket required. No fee.
Upon completion of this session, participants should be able to identify differences and
Credit: 4.50 CME / 5.40 CE
similarities in patients with asthma vs. COPD.
Moderators: Nina A. Zimmermann, MSN RN ANP-BC AE-C
Debra A. Sedlak, MSN CPNP Clinical Research Workshop
8:00 Introduction
1102 The Anatomy of the Clinical Trial Agreement
Debra A. Sedlak, MSN CPNP
8:15 Patients’ Attitudes and Beliefs About Complementary and 8:00 to 9:15 am
Alternative Medicine Use for Asthma Self-Management Marriott North Tower, Lobby Level, Torrey Pines 1 & 2
Maureen George, PhD RN AE-C FAAN Credit: 1.25 CME / 1.50 CE
Moderator: Christopher Chang, MD PhD FAAAAI
9:00 Bronchial Thermoplasty for the Treatment of Severe Asthma
Mario Castro, MD MPH The Anatomy of the Clinical Trial Agreement and Negotiating a
Profitable Budget
9:45 Question & Answer
Cheryl Koff Bernstein, RN BSN CCRC
10:00 Vitamin D: Sunlight at the End of the Tunnel
Upon completion of this session, participants should be able to: Identify and discuss the
Nicolette De Jong, PhD
language used in reciprocal or crossed indemnification and offer alternative indemnifica-
10:45 Food Allergy: New Therapies on the Horizon tion language during contract negotiations; Identify and discuss important sections of the
Beth D. Strong, RN CCRC contract such as liability insurance, language used to describe adherence to the protocol,
payment, study termination and offer alternative language; Discuss successful methods
11:30 Managing Atopic Dermatitis: Itching the Night Away!
and techniques used during contract and budget negotiations with the sponsor.
Karol G. Timmons, RN MS CPNP
12:15 Question & Answer Chrysalis Project
Upon completion of this session, participants should be able to: Evaluate how patients'
health beliefs impact asthma self-management; Identify asthma patients who may 1111 2014 Chrysalis Project Program
benefit from alternative treatments such as broncial thermoplasty and Vitamin D therapy;
7:30 am to 2:00 pm
Define new and appropriate treatment strategies for common food allergies and atopic
Marriott North Tower, Lobby Level, Rancho Santa Fe 1-3
dermatitis.
Pre-registration and ticket required. No fee. Continental breakfast and
Allied Health Advanced Practice Course Breakout box lunch included.
Credit: No CME / No CE
Sessions
7:30 Breakfast
12:30 to 2:00 pm
8:00 Welcome
Separate pre-registration, ticket and fee from the 1101 Advanced
Thomas A. Fleisher, MD FAAAAI
Practice Course. Pre-registration and ticket required. Fee: $20.
Kimberly A. Risma, MD PhD FAAAAI
Box lunch included. Sessions and meals are limited to registered
8:05 Welcome from the AAAAI President
attendees.
Linda Cox, MD FAAAAI
Credit: 1.50 CME / 1.80 CE
8:15 Food Allergy
1101A Cough/Chronic Cough
A. Wesley Burks, MD FAAAAI
Marriott North Tower, Lobby Level, Marriott Hall Salon 5
8:45 Eosinophilic Disorders
Nina A. Zimmermann, MSN RN ANP-BC AE-C
Paneez Khoury, MD
Jeanette L. Arnold, MSN RN C-FNP
9:15 Immunodeficiency
Upon completion of this session, participants should be able to discuss the diagnostic
Kathleen E. Sullivan, MD PhD FAAAAI
evaluation and therapeutic options to treat chronic cough.
9:45 Break
1101B Is This Anaphylaxis?
10:00 Asthma
Marriott North Tower, Lobby Level, Marriott Hall Salon 6
Rohit Katial, MD FAAAAI
Gabriel Ortiz, MPAS PA-C DFAAPA
10:30 Atopic Dermatitis
Vivian P. Hernandez-Trujillo, MD FAAAAI
Donald Y.M. Leung, MD PhD FAAAAI
Upon completion of this session, participants should be able to describe anaphylaxis and
the initiation of appropriate treatment. 11:00 Academic Career Paths
Kimberly A. Risma, MD PhD FAAAAI
1101C Opening Pandora’s Box: Asking the Right
11:20 Industry Career Paths
Questions
Daniel C. Adelman, MD FAAAAI
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2
11:40 Private Practice Career Paths
David Wayne Unkle, MSN APN FCCM
Adina Kay Knight, MD FAAAAI
Anthony J. Ricketti, MD FACAI FCCP
12:00 Chrysalis Project Program Luncheon with FIT Mentors
Upon completion of this session, participants should be able to discuss strategies for
interpreting information given by our patients.
26
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Program Directors Course Course
1112 How to Develop and Maintain Excellence in 1202 NIAID: Epigenetics in Asthma and Allergy: Basic
Allergy/Immunology Fellowships: Boot Camp for Concepts and Recent Advances
Program Directors and Clinical Faculty 9:00 am to 12:00 pm
8:15 am to 12:00 pm Convention Center, Upper Level, Room 11AB
Marriott North Tower, Lobby Level, San Diego Ballroom Salon A Credit: 2.75 CME / 3.30 CE
Pre-registration and ticket required. No fee. Continental breakfast Moderator: Alkis Togias, MD FAAAAI
included. 9:00 Epigenetics: Basic Concepts
Credit: No CME / No CE Bing Ren, PhD
Moderator: Asriani M. Chiu, MD FAAAAI 9:25 Asthma and Allergy Epigenetics: What Have We Learned So Far?
8:15 Continental Breakfast David A. Schwartz, MD
8:45 The ABC’s of Post-Graduate Medical Education (AAAAI, ABAI, 9:50 Environmental Influences on the Epigenome
ACGME) and Beyond Rachel L. Miller, MD FAAAAI
Mary Beth Fasano, MD FAAAAI 10:15 Break
9:15 The Nuts and Bolts of Building an A/I Fellowship Program: 10:30 Epigenetic Regulation of the Immune System in Relation to
Program Requirements in the Era of the Next Accreditation Allergy and Asthma
System Kari C. Nadeau, MD PhD FAAAAI
Jeffrey R. Stokes, MD FAAAAI 10:55 The Epithelial Cell Epigenome and its Relation to Asthma
9:45 Communications and Reference Tools: iPads, iPhones and Carole Ober, PhD
PubMed 11:20 Epigenetic Regulation of Arachidonic Acid Metabolism and its
Thanai Pongdee, MD FAAAAI Clinical Implications
10:15 Break Benjamin A. Raby, MD MPH
10:30 How to Use the Milestones for Effective Learner Assessment 11:45 Question & Answer
Michael R. Nelson, MD PhD FAAAAI Upon completion of this session, participants should be able to: Describe the importance
11:00 Curriculum Design: Tips for Teaching Generation Y of epigenetic changes and their potential impact on our understanding and treatment of
allergic diseases and asthma; Identify specific cells and pathways relevant to allergy and
Fanny Silviu-Dan, MD FAAAAI
asthma where epigenetic changes may influence disease.
11:30 Directing an A/I Fellowship Program: Ask the Expert Panel
Discussion Course
Mariana C. Castells, MD PhD FAAAAI
Lawrence B. Schwartz, MD PhD FAAAAI 1203 Technology in the Clinical Practice Made
Elizabeth A. Secord, MD FAAAAI Ridiculously Simple
Upon completion of this session, participants should be able to: Enhance the teaching 9:00 am to 12:00 pm
skills of upcoming, new and current allergy/immunology fellowship program directors and
Convention Center, Mezzanine Level, Room 14AB
associate program directors, core A/I fellowship faculty and community volunteer clinical
Credit: 3.00 CME / 3.40 CE
faculty; Provide practical tips for developing and enhancing an A/I fellowship program in
the context of the next accreditation system; Support the development of allergy/immu- Moderator: Tao T. Le, MD MHS FAAAAI
nology program directors, fellowship core faculty and community volunteer clinical faculty; 9:00 What Can Technology Do for Your Practice
Improve the quality of allergy/immunology fellowship training. Tao T. Le, MD MHS FAAAAI
9:20 EHRs and the Meaningful Use of Life
Course A. Sean McKnight, MD FAAAAI
1201 Advanced Course in Pollen Identification 9:50 Practice Management Systems and Other Office Automation Tools
9:00 am to 12:00 pm Linda D. Green, MD FAAAAI
Marriott North Tower, Lobby Level, Marriott Hall Salon 3 10:20 Break
Pre-registration and ticket required. Fee: $125. 10:30 iPhones, iPads, Androids, Oh My!
Credit: 3.00 CME / 3.60 CE Melinda M. Rathkopf, MD FAAAAI
Moderator: Estelle Levetin, PhD FAAAAI 11:00 Social Media Tools for Marketing and Communications
9:00 Asteraceae Pollen Ves Dimov, MD
Peter Van De Water, PhD 11:30 Making the Technology Work and Pay Off
9:30 Hands-On Instruction; Question & Answer David J. Shulan, MD FAAAAI
10:00 Betulaceae Pollen 11:50 Question & Answer
Richard W. Weber, MD FAAAAI Upon completion of this session, participants should be able to: Describe EHRs, practice
10:30 Hands-On Instruction; Question & Answer management systems and office automation technologies appropriate for the clinical
practice; Explain the role of mobile technologies in the practice; List web and social media
11:00 Other Triporate and Tricolporate Pollen
tools for practice marketing and communications.
Estelle Levetin, PhD FAAAAI
11:30 Hands-On Instruction; Question & Answer
Upon completion of this session, participants should be able to: Differentiate pollen in
the birch family and related tri-porate pollen types; Recognize difficult tricolporate pollen
types; Differentiate asteraceae pollen other than ragweed.
27
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Course Course
1204 Endoscopic Evaluation and Management of 1206 Primary Immunodeficiency Diseases: What Do I
Chronic Rhinosinusitis (Pre- and Post-Surgery) Do with My Patient? From Start to Finish
Including Cultures 9:00 am to 12:00 pm
9:00 am to 12:00 pm Convention Center, Upper Level, Ballroom 6CF
Convention Center, Upper Level, Room 3 Credit: 2.75 CME / 3.30 CE
Pre-registration and ticket required. No fee. Moderator: Lisa J. Kobrynski, MD MPH FAAAAI
Credit: 3.00 CME / 3.40 CE 9:00 Who Needs Evaluation for Immunodeficiency?
Moderator: Anju T. Peters, MD FAAAAI M. Teresa De La Morena, MD
9:00 Anatomy of the Sinuses 9:25 Assessing Innate and Adaptive Humoral Immunity
Todd T. Kingdom, MD Francisco A. Bonilla, MD PhD FAAAAI
9:20 Radiology of the Sinuses 9:50 Assessing Innate and Adaptive Cellular Immunity
S. James Zinreich, MD I. Celine Hanson, MD FAAAAI
10:00 Endoscopic Evaluation of the Sinuses Including Cultures: Video 10:15 Question & Answer
and Lecture 10:35 Break
Wellington S. Tichenor, MD FAAAAI 10:50 Therapies for Innate and Adaptive Humoral Immunodeficiency
10:20 Break Vincent R. Bonagura, MD FAAAAI
10:30 Surgical Evaluation 11:15 Therapies for Innate and Adaptive Cellular Immunodeficiency
Robert C. Kern, MD Mark Ballow, MD FAAAAI
10:50 Endoscopic Evaluation of the Sinuses: Post-Surgical 11:40 Question & Answer
Wellington S. Tichenor, MD FAAAAI Upon completion of this session, participants should be able to: Describe a general ap-
11:10 Case Management Studies: Question & Answer proach to a patient with recurrent infections or other presentation consistent with PID;
Daniel L. Hamilos, MD Discuss the stepwise approach to the diagnosis of PID and how to apply advanced and
specialized tests, possibly in conjunction with guidance from a tertiary provider; List
Upon completion of this session, participants should be able to: Describe the anatomy of
the different modalities available for therapy, general principles of their application and
the paranasal sinuses and identify pathology on CT scan; Recall indications for surgery
resources for guidance in unusual or complex situations.
and complications of surgery; Perform endoscopy in patients with CRS as well as cultures
of the middle meatus and/or sinuses and review management of complicated sinusitis.
Course
Course 1207 Drug Hypersensitivity
1205 Difficult Cases (Part 1) 9:00 am to 12:00 pm
Convention Center, Upper Level, Ballroom 6DE
9:00 am to 12:00 pm
Credit: 2.75 CME / 3.30 CE
Convention Center, Mezzanine Level, Room 15AB
Moderator: Rebecca S. Gruchalla, MD PhD FAAAAI
Pre-registration and ticket required. No fee.
Credit: 2.75 CME / 3.20 CE 9:00 Symptoms and Skin Testing for Type I Chemotherapy Drug
Moderators: David W. Hauswirth, MD FAAAAI Hypersensitivity
Joyce E. Yu, MD David E. Sloane, MD
9:00 Hypereosinophilic Disorders (Not EoE) 9:50 Break
Amy D. Klion, MD 10:05 Patch Testing in Drug Allergy
Princess U. Ogbogu, MD FAAAAI Antonino G. Romano, MD
9:35 Itching Without Rash 10:55 Antibiotic Skin Testing
Cem Akin, MD PhD FAAAAI Anahita F. Dioun, MD FAAAAI
Gerald B. Lee, MD 11:45 Question & Answer
10:10 Break Upon completion of this session, participants should be able to: List the symptoms of Type
10:30 Peri-Operative Anaphylaxis I drug hypersensitivity reactions; Identify symptoms of Type IV drug hypersensitivity reac-
tions; Describe diagnostic tools for Type I and Type IV drug hypersensitivity reactions.
Phillip L. Lieberman, MD FAAAAI
Joel M. Hartman, MD
11:05 What the Allergist/Immunologist Sees That is Not Allergy
Dennis K. Ledford, MD FAAAAI
Eugene M. Choo, MD FAAAAI
11:40 Question & Answer
Upon completion of this session, participants should be able to discuss diagnostic and
clinical management challenges encountered in allergy, asthma and immunology practice.
28
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Course 1209A/D Hands-On Workshop: Allergy Skin Testing
Convention Center, Upper Level, Room 32AB
1208 Dermatology for the Allergist: Diagnosis and
Credit: 1.00 CME / 1.20 CE
Therapeutics Boot Camp
Peter S. Creticos, MD FAAAAI
9:00 am to 12:00 pm Jay A. Lieberman, MD
Convention Center, Mezzanine Level, Room 16AB John Oppenheimer, MD FAAAAI
Pre-registration and ticket required. No fee. Anita Trikha, MD
Credit: 3.00 CME / 3.40 CE Upon completion of this session, participants should be able to: Compare the different
Moderator: Lynda C. Schneider, MD FAAAAI devices and other equipment and their characteristics; Explain the importance of stan-
9:00 Common Dermatologic Diseases with Mimics and Crossovers in dardized allergen extracts for the test result; Demonstrate the importance of standardized
testing technique and its control by proficiency testing.
Allergy: Overview from a Dermatology Perspective
Peter A. Lio, MD 1209B/C Coding and Regulatory Issues Related to
9:30 Therapies for Dermatitis Allergy Diagnosis and Treatment
Lawrence F. Eichenfield, MD Convention Center, Upper Level, Room 33AB
10:00 Question & Answer Credit: 1.00 CME / 1.20 CE
10:10 Break Donald W. Aaronson, MD FAAAAI
10:20 Video Demonstration: Biopsies, Scrapings and Patent Testing David A. Brown, MD
Lawrence F. Eichenfield, MD Gary N. Gross, MD FAAAAI
Upon completion of this session, participants should be able to apply adequately the cod-
11:00 Hands-On Learning
ing, documentation and regulatory guidelines for immunotherapy.
Lawrence F. Eichenfield, MD
Luz S. Fonacier, MD FAAAAI
Course
Peter A. Lio, MD
Upon completion of this session, participants should be able to: Discuss common diag- 1210 Principles of Healthy Homes: What to Look for
nostic tests applicable to eczemas; Outline basic skin care for allergic skin diseases and and How to Help Your Patients or Evaluation and
avoidance of pitfalls.
Mitigation
Course 9:00 am to 12:00 pm
1209 Allergen Immunotherapy: The Nuts and the Bolts Convention Center, Upper Level, Room 33C
Pre-registration and ticket required. No fee.
(Part 1)
Credit: 2.75 CME / 3.30 CE
9:00 to 10:00 am
Moderator: Jay M. Portnoy, MD FAAAAI
Convention Center, Upper Level, Room 30CDE
9:00 The Indoor Biome and Healthy Housing
Pre-registration and ticket required. No fee.
Christina E. Ciaccio, MD FAAAAI
Credit: 1.00 CME / 1.20 CE
9:30 How to Evaluate a Problem Home: Tools You Can Use
Moderator: Matthew A. Rank, MD FAAAAI
Kevin Kennedy, MPH CIEC
9:00 Advances in Allergy Diagnostic Testing: Component Resolved
10:00 Break
Diagnosis to Identify Specific Allergens
10:15 Working With Patients: Taking an Environmental Healthy History
Joerg R. Kleine-Tebbe, MD FAAAAI
James L. Sublett, MD FAAAAI
9:30 Food Immunotherapy: Baked, Shaken or Stirred: Is it Ready to be
10:45 Remediating and Maintaining a Healthy Home
Served?
Paul J. Dowling, MD FAAAAI
Robert A. Wood, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss how diagnosis 11:15 What Works, What Doesn’t and What Needs to be Done
might improve with in vitro techniques to come; Discuss clinical readiness of food im- Wanda Phipatanakul, MD MS FAAAAI
munotherapy. 11:45 Question & Answer
Course Breakout Sessions Upon completion of this session, participants should be able to: Identify the principles of
healthy homes and the relative importance of each; Identify the basic steps in taking an
Attendees will rotate between the following two workshops. environmental history about a patient’s home environment; Describe the essential steps to
Pre-registration and ticket required. Fee: $25. Sessions are limited to assess home environmental hazards and conditions and mitigation.
registered attendees.
10:00 am to 12:00 pm
29
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Allied Health Workshop Allied Health Workshop
1301 Psychosocial Well-Being: Living with Food 1501 Ask the Expert: Roundtable Discussion
Allergies 12:30 to 1:30 pm
9:30 to 10:45 am Marriott North Tower, Lobby Level, Presidio Rooms 1 & 2
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 Pre-registration and ticket required. Fee: $40. Box lunch included.
Credit: 1.25 CME / 1.50 CE Credit: 1.00 CME / 1.20 CE
Moderator: John D. Milewski, Med. Admin.
Panelists:
Joan E. Hawkins
Jennifer M. Darr, MSW LCSW
Teresa Thompson, CPC CMSCS CCC
Melissa T. Korenblat-Hanin, ACSW LCSW
11:30 Question & Answer
Upon completion of this session, participants should be able to: Describe the psychoso-
cial dynamics of living with food allergies: challenges, emotions and accomplishments; Upon completion of this session, participants should be able to: Identify coding and ICD10
Discuss approaches that build and enhance stability, security and sensibility using chal- challenges in 2014; Discuss best practices for motivating employees; Identify how to
lenging case scenarios; Identify successful resources for assisting the food allergic patient assess your clinical practices.
and family.
Program Directors’ Business Meeting
Allied Health Workshop 2:00 to 4:00 pm
1302 The Asthma Action Plan: Use of Simulation to Marriott North Tower, Lobby Level, San Diego Ballroom Salon A
All Program Directors and Co-Directors are invited to attend this
Teach and Reinforce
business meeting.
9:30 to 10:45 am
Marriott North Tower, Lobby Level, Atlanta & Chicago
Credit: 1.25 CME / 1.50 CE Course
Moderator: Maureen George, PhD RN AE-C FAAN 1601 Advanced Course in Fungal Spore Identification
Using Simulation to Improve Patient Education About the Asthma 2:00 to 5:00 pm
Action Plan Marriott North Tower, Lobby Level, Marriott Hall Salon 3
Anne E. Borgmeyer, MSN RN CPNP AE-C Pre-registration and ticket required. Fee: $125.
Upon completion of this session, participants should be able to: Describe principles of Credit: 3.00 CME / 3.60 CE
patient and family-focused education; Review the use of simulation to teach patient
Moderator: Estelle Levetin, PhD FAAAAI
communication strategies to providers; List the key principles of the Asthma Action Plan to
improve self-management and asthma control. 2:00 Basidiospore Identification
Estelle Levetin, PhD FAAAAI
Allied Health Workshop 2:30 Hands-On Instruction; Question & Answer
3:00 Ascospore Identification
1401 Developing and Maintaining a Successful
W. Elliott Horner, PhD LEED AP FAAAAI
Research Center: Secrets of a Trade
3:30 Hands-On Instruction; Question & Answer
11:00 am to 12:15 pm
4:00 Challenging Spore Types
Marriott North Tower, Lobby Level, Torrey Pines 1 & 2
James Scott, PhD
Credit: 1.25 CME / 1.50 CE
4:30 Hands-On Instruction; Question & Answer
Moderator: Craig F. LaForce, MD FAAAAI
Upon completion of this session, participants should be able to: Interpret common basid-
Cheryl Koff Bernstein, RN BSN CCRC
iospores; Interpret common ascospores; Describe Fusarium, Penicillium/Aspergillus and
David I. Bernstein, MD FAAAAI
other difficult spore types.
Upon completion of this session, participants should be able to: Discuss the infrastruc-
ture necessary to establish a successful and productive research center; Discuss the
challenges of maintaining a successful research center while competing in global clinical
trials; Identify strategies for promoting your research center and enhancing your chances
for clinical trial selection.
Allied Health Workshop
1402 The Food Allergy Spectrum: Not Just Peanuts,
Eggs and Milk
11:00 am to 12:15 pm
Marriott North Tower, Lobby Level, Torrey Pines 3
Credit: 1.25 CME / 1.50 CE
Panelists:
Pinkus Goldberg, MD FAAAAI
Karen S. Rance, DNP RN CPNP AE-C
Upon completion of this session, participants should be able to: Identify an evidence-
based approach to managing food allergy patients with less common allergens; Discuss
how to screen for possible sensitivity to food additives and preservatives; Describe a
management approach for patients with multiple food allergies.
30
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Course Course
1602 NIAID: Recent Advances in Biomarkers of Allergy 1604 Difficult Cases (Part 2)
and Asthma 2:00 to 5:00 pm
2:00 to 5:00 pm Convention Center, Mezzanine Level, Room 15AB
Convention Center, Upper Level, Room 11AB Pre-registration and ticket required. No fee.
Credit: 2.75 CME / 3.30 CE Credit: 2.75 CME / 3.20 CE
Moderator: Marshall Plaut, MD FAAAAI Moderators: Jason W. Caldwell, DO FAAAAI
Michael H. Land, MD FAAAAI
2:00 Allergen Challenge as a Biomarker of Disease Severity and of the
Effects of Treatment 2:00 COPD vs. Asthma
Stephen R. Durham, MA MD FRCP William W. Busse, MD FAAAAI
Matthew C. Bell, MD
2:25 Transcriptomic Changes After Allergen Exposure
Sunil K. Ahuja, MD 2:35 Implant Allergy
Luz S. Fonacier, MD FAAAAI
2:50 Basophil Activation as a Predictor of Food Allergen Severity
Haejin Kim, MD
Alexandra F. Santos, MD MSc
3:10 Break
3:15 Break
3:30 New Immune Deficiencies
3:30 Basophil Activation as a Biomarker of Food Allergy and Asthma
Gulbu Uzel, MD
Wayne G. Shreffler, MD PhD FAAAAI
Monica G. Lawrence, MD
3:55 T Regulatory Cells as Markers of Allergen Immunotherapy
4:05 Mystery Rashes
Andrew D. Luster, MD PhD
Lisa A. Beck, MD FAAAAI
4:20 CD27 Effector Cell Depletion During Allergen Immunotherapy
Anne Marie Singh, MD
Erik R. Wambre, PhD
4:40 Question & Answer
4:45 Question & Answer
Upon completion of this session, participants should be able to discuss diagnostic and
Upon completion of this session, participants should be able to: Explain how mediators
clinical management challenges encountered in allergy, asthma and immunology practice.
produced following allergen challenge predict the status of allergic diseases; Describe the
relationship of successful allergen immunotherapy to effects on circulating T cell subsets
Course
and antibody responses; Appreciate the value of measuring peripheral blood basophil
activation in allergic diseases and asthma.
1605 Mast Cell Activation Syndromes: From
Course Anaphylaxis to Mastocytosis
2:00 to 5:00 pm
1603 Finding a Job and Getting Started in Practice
Convention Center, Upper Level, Room 6A
2:00 to 5:00 pm Credit: 2.75 CME / 3.30 CE
Convention Center, Upper Level, Room 2 Moderator: Luis Escribano, MD PhD FAAAAI
Credit: 3.00 CME / 3.40 CE
2:00 Anaphylaxis to Hymenoptera Venom
Moderator: Tao T. Le, MD MHS FAAAAI
Patrizia Bonadonna, MD PhD
2:00 Overview and Introductions
2:30 Mastocytosis: Role of Tryptase and C-Kit Mutations
Tao T. Le, MD MHS FAAAAI
Cem Akin, MD PhD FAAAAI
2:05 Finding a Job and Negotiating the Agreement
3:00 Break
Tao T. Le, MD MHS FAAAAI
3:15 Non-Clonal Mast Cell Activation Syndrome
2:40 Getting Licensed and Transitioning into Practice
Mariana C. Castells, MD PhD FAAAAI
Brian A. Smart, MD FAAAAI
3:45 When and How to Perform a Bone Marrow Study in MCAS:
2:55 Break
Practical Recommendations
3:05 Secrets of an Efficient Allergy Practice Luis Escribano, MD PhD FAAAAI
David L. Patterson, MD MS MBA FAAAAI
4:15 Idiopathic Anaphylaxis
3:40 Practice Finances 101 Paul A. Greenberger, MD FAAAAI
Marshall P. Grodofsky, MD FAAAAI
4:45 Question & Answer
4:15 Marketing Your Practice and Referral Development Upon completion of this session, participants should be able to: Discuss the symptoms
Stanley M. Fineman, MD MBA FAAAAI and presentation of mast cell activation syndromes (MCAS); Outline the role of tryptase
4:50 Question & Answer and c-kit mutations in MCAS; Describe management options for MCAS.
Upon completion of this session, participants should be able to: Outline how to identify
and join the right practice opportunity; Discuss the fundamentals of office management;
Identify strategies for marketing a practice and building a patient base.
31
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Course Upon completion of this session, participants should be able to: Discuss ethnic and
geographical differences in PID prevalence and clinical presentation around the world;
1606 Review of Systemic Autoimmune Disease and Discuss international vaccine programs and challenges posed for the PID community;
Treatment Review clinical scenarios of PID management in different settings around the world.
2:00 to 5:00 pm
Course
Convention Center, Upper Level, Ballroom 6B
Credit: 3.00 CME / 3.60 CE 1608 NIEHS: Exposure to Indoor Allergens and
Moderator: Arnold I. Levinson, MD FAAAAI Endotoxin in Relation to Allergic Disease: Results
2:00 Update on Laboratory Diagnosis of Systemic Autoimmune from NHANES 2005-2006
Disease
2:00 to 5:00 pm
David P. Huston, MD FAAAAI
Convention Center, Upper Level, Ballroom 6DE
2:30 ACR Updated Recommendations for Disease-Modifying
Credit: 2.75 CME / 3.20 CE
Antirheumatic Drugs and Biologic Agents in the Treatment of RA
Moderators: Paivi M. Salo, PhD
Arthur Kavanaugh, MD FAAAAI
Darryl C. Zeldin, MD
3:00 Question & Answer
2:00 Overview of the NHANES 2005-2006 Allergy Component
3:15 The Spectrum of Vasculitis: New Insights into Pathogenesis and Darryl C. Zeldin, MD
Treatment
2:20 Multiplexed Allergen Measurements: New Standards and
Richard Keating, MD
Performance Parameters
3:45 New Treatment Modalities for Lupus Eva-Maria King, PhD
Mary Anne Dooley, MD
2:40 NHANES 2005-2006: Getting to Grips with the Big Data
4:15 Susceptibility to Infections in Autoimmune Disease: Is it the Agustin Calatroni, MA MS
Disease or the Treatment?
3:00 Break
John J. Cush, MD
3:20 IgE Sensitization and Current Allergen Exposure: Implications for
4:45 Question & Answer
Environmental Intervention
Upon completion of this session, participants should be able to: Interpret screening and Herman Mitchell, PhD
follow-up reflex testing in the diagnosis of autoimmune disease; Review the latest treat-
3:40 Environmental Exposures and Allergy Symptoms
ment guidelines for rheumatoid arthritis; Describe the organ systems lupus can affect and
the downstream sequelae of complement activation. Paivi M. Salo, PhD
4:00 Which Combinations of IgE Clusters and Exposures Have the
Course Greatest Impact on Asthma?
Peter J. Gergen, MD MPH
1607 Primary Immune Deficiency: A Global Perspective
4:20 Endotoxin Exposure Assessment and Respiratory Disease
2:00 to 5:00 pm
Peter S. Thorne, PhD
Convention Center, Upper Level, Ballroom 6CF
4:40 Question & Answer
Credit: 3.00 CME / 3.40 CE
Upon completion of this session, participants should be able to: Interpret the role that
Moderator: Motohiro Ebisawa, MD PhD FAAAAI
allergen/endotoxin exposures and allergic sensitization play in allergic diseases; Apply
2:00 An Overview of Primary Immunodeficiency Diseases Around the new, standardized methods in indoor allergen assessment; Review strategic objectives of
World NHANES and the allergy component.
Fred Modell
2:25 Vaccine-Associated Paralytic Polio and Other Live Attenuated Course
Vaccine-Associated Disease in Immunodeficient Infants
1609 Allergen Immunotherapy: The Nuts and the Bolts
Antonio Condino-Neto, MD PhD
(Part 2)
2:50 Clinical Cases: Diagnosis and Management of Primary
Immunodeficency Around the World 2:00 to 3:00 pm
Elham M. Hossny, MD PhD FAAAAI Convention Center, Upper Level, Room 30CDE
Pre-registration and ticket required. No fee.
3:15 Question & Answer
Credit: 1.00 CME / 1.20 CE
3:25 Break
Moderator: Michael R. Nelson, MD PhD FAAAAI
Moderators: Elham M. Hossny, MD PhD FAAAAI
2:00 SCIT and SLIT: Optimal Dosing, Regimen and Duration
Mona I. Kidon, MD FAAAAI
Harold S. Nelson, MD FAAAAI
3:35 Defects of Human Immunity and Mycobacterium Diseases Around
2:30 Allergen Immunotherapy: Practical Considerations, Cost-
the World
Effectiveness, Adherence and Quality of Life
Stephanie Boisson-Dupuis, MD
Cheryl S. Hankin, PhD
4:00 Molecular Mechanisms of Hyper IgE Syndromes Upon completion of this session, participants should be able to: Describe how immuno-
Speaker to be announced. therapy can easily be dosed and the knowledge gaps we still have in this field; Discuss
4:25 Malnutrition, Vitamin Deficiencies, the Immune System and when doses might need to be adjusted for SCIT and for SLIT.
Infections: Time to Revisit Our Knowledge
Raz Somech, MD PhD
4:50 Question & Answer
32
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Course Breakout Sessions Course
Attendees may attend one of the following sessions. 1611 Career Building for the Junior Investigator
Pre-registration and ticket required. Fee: $25. Sessions are limited to 2:00 to 5:00 pm
registered attendees. Convention Center, Upper Level, Room 1AB
3:00 to 5:00 pm Credit: 2.75 CME / 3.20 CE
1609A/D Hands-On Workshop: Media Fill Test and Moderator: Laura B. Fanning, MD
Extract Preparation Management 2:00 Panel Discussion: Career Advice from Established Investigators:
Convention Center, Upper Level, Room 32AB Strategies to Establish Scientific/Clinical Expertise
Credit: 1.00 CME / 1.20 CE Effective Time Management
Donald W. Aaronson, MD FAAAAI Effective Lab Management
Michael S. Blaiss, MD FAAAAI Andrea J. Apter, MD MA MSc FAAAAI
Susan E. Kosisky, BS MHA Kathleen C. Barnes, PhD FAAAAI
Cecilia Mikita, MD MPH FAAAAI Joshua A. Boyce, MD FAAAAI
Michael R. Nelson, MD PhD FAAAAI James E. Gern, MD FAAAAI
Upon completion of this session, participants should be able to demonstrate the ability to Mitchell H. Grayson, MD FAAAAI
make a sterile immunotherapy vial.
3:05 Question & Answer
1609B/C Allergen Immunotherapy Prescription Writing:
3:20 Break
Cross-Reactivity, Proteolytic Enzymes, Diluents 3:40 Panel Discussion: Career Advice from Junior Investigators:
and Other Factors Time Management Strategies
Convention Center, Upper Level, Room 33AB Strategies for Work and Family Life Balance
Credit: 1.00 CME / 1.20 CE Data Management
Rohit Katial, MD FAAAAI
Grant Writing
Bryan L. Martin, DO FAAAAI
Nora A. Barrett, MD FAAAAI
Michael S. Tankersley, MD FAAAAI
Patrick J. Brennan, MD PhD
Upon completion of this session, participants should be able to demonstrate the proper Taylor A. Doherty, MD FAAAAI
method for writing immunotherapy prescriptions for optimal efficacy and safety.
Tanya M. Laidlaw, MD FAAAAI
Brian P. Vickery, MD FAAAAI
Course
4:45 Question & Answer
1610 Personalized Medicine Approaches in Asthma Upon completion of this session, participants should be able to: Discuss how to develop a
and Allergy specific clinical and scientific expertise; Discuss how to manage their time effectively and
how to choose roles and projects wisely; Describe benchmarks of success.
2:00 to 5:00 pm
Convention Center, Upper Level, Room 8 Course
Credit: 2.75 CME / 3.20 CE
1612 Hands-On Rhinolaryngoscopy
Moderator: Antonella Cianferoni, MD PhD
2:00 to 5:00 pm
2:00 CyTOF Flow: The New Frontier
Convention Center, Upper Level, Room 30AB
Jonathan M. Irish, PhD
Pre-registration and ticket required. Fee: $50.
2:30 Lessons Learned from Genetic Diseases of Allergy
Credit: 2.75 CME / 3.30 CE
Joshua D. Milner, MD
Moderator: Jerald W. Koepke, MD FAAAAI
3:10 Break
2:00 Intro to Rhinolaryngoscopy
3:30 Using Biomarkers and Genomics to Personalize Therapeutics for
Jerald W. Koepke, MD FAAAAI
Allergy and Asthma
3:15 Break
Stanley J. Szefler, MD FAAAAI
3:30 Hands-On Instruction
4:05 Establishing a Personalized Medicine Program: The Harvard
Allen D. Adinoff, MD FAAAAI
Experience
Kevin R. Murphy, MD
Scott T. Weiss, MD MS
Grant C. Olson, MD
4:40 Question & Answer
Donald W. Pulver, MD FAAAAI
Upon completion of this session, participants should be able to: Discuss the availability
C. Ross Westley, MD FAAAAI
for genetic variation in disease risk, progression and therapy; Describe readily available
predictive tests (genetic and non-genetic); Describe the use and cost effectiveness of a Upon completion of this session, participants should be able to: Describe the surgical
personalized medicine approach in clinical practice. anatomy of the upper airway, including the nasal cavity, pharynx and larynx; Identify
examples of normal and abnormal anatomy, as well as disease presentations and
post-operative changes found with endoscopic examination of the upper airway; Identify
indications for and the use of the fiberoptic rhinoscope in the allergist’s office.
33
Allied Health Session ticket required fee required included in the Virtual Annual Meeting
FRIDAY, FEBRUARY 28
Course Problem-Based Learning Workshop
1613 Interpretation of Pulmonary Function Tests (PFTs) 1801 Diagnosis of Patients with Defects in Innate
2:00 to 5:00 pm Immunity Including TLR Pathway Defects
Convention Center, Upper Level, Room 33C
5:00 to 6:15 pm
Pre-registration and ticket required. No fee.
Convention Center, Upper Level, Room 3
Credit: 3.00 CME / 3.50 CE
Pre-registration and ticket required. Fee: $50.
Moderator: Mark F. Sands, MD FAAAAI
Credit: 1.25 CME / 1.50 CE
2:00 Introductory Remarks PBL Facilitator: Richard L. Wasserman, MD PhD FAAAAI
2:05 Pathophysiology and the PFT Content Lecturer: Dinakantha Kumararatne, MD PhD
Mark F. Sands, MD FAAAAI Upon completion of this session, participants should be able to: Describe the currently
2:30 Performing PFT: Video Demonstration known causes of defective innate immunity; Describe the clinical presentation of defects
John M. Weiler, MD FAAAAI in innate immunity; Discuss the selection and interpretation of laboratory tests to diagnose
defects in innate immunity.
2:40 Interpretation of the PFT: Putting it All Together
Donald P. Tashkin, MD Q & A Workshop
3:10 Question & Answer
1802 Difficult to Manage Asthma: The Very Young, the
3:25 Break
3:30 Hands-On Workshop Very Old and the Obese
Donald W. Cockcroft, MD FAAAAI 5:00 to 6:15 pm
Meredith C. McCormack, MD Convention Center, Mezzanine Level, Room 14AB
Riccardo Polosa, MD PhD FAAAAI Credit: 1.25 CME / 1.50 CE
Mark F. Sands, MD FAAAAI Moderator: Timothy J. Craig, DO FAAAAI
Donald P. Tashkin, MD 5:00 What to Do When Your Patient Can’t Tell You What’s Wrong:
John M. Weiler, MD FAAAAI Challenges in the Diagnosis and Management of Asthma in
Upon completion of this session, participants should be able to: Describe the components Children Under Age Five
of pulmonary function testing; Recognize simple and complex obstructive and restrictive Joseph D. Spahn, MD
pulmonary abnormalities; Interpret PFTs from asthma and COPD to fixed and variable
5:15 Pitfalls in the Diagnosis and Management of Asthma in Older
obstructive abnormalities, as well as interstitial and other restrictive diseases.
Adults: An Evidence-Based Update
Clinical Research Symposium Tolly Epstein, MD MS
5:30 New Insights into the Obese Asthma Phenotype: Diagnostic and
1621 Tools of the Trade Therapeutic Challenges in Obese Asthmatics
2:00 to 3:15 pm Juan C. Celedon, MD DrPH FAAAAI
Marriott North Tower, Lobby Level, Torrey Pines 3 5:45 Question & Answer
Credit: 1.25 CME / 1.50 CE Upon completion of this session, participants should be able to: Identify emerging diag-
Moderator: Jaime E. Ross, RN nostic modalities for asthma that may be useful in children under age 5 years; Develop
2:00 What You Need to Know to Prepare for an FDA Audit strategies to distinguish asthma from other potential comorbid conditions in elderly
asthmatics and implement age-appropriate management strategies in older asthmatics;
Kim E. Mudd, RN MSN CCRP
Summarize recent data regarding the obese asthmatic phenotype and critically assess
2:30 Developing Your Monitoring Plan: Improving the Quality of the current management strategies in this subgroup of asthmatics.
Research
Janet S. Kamilaris, RN Q & A Workshop
3:00 Question & Answer
1803 What are Damp Buildings and How Do They
Upon completion of this session, participants should be able to: Describe the components
of a monitoring plan; List the methods to keep a clinical trial site ready for an audit; Cause Problems?
Identify the proper use of a note to file and describe its limitations. 5:00 to 6:15 pm
Convention Center, Upper Level, Room 5AB
Allied Health Plenary Credit: 1.25 CME / 1.50 CE
1701 Cybersecurity: Technology in Practice Moderator: Jay M.Portnoy, MD FAAAAI
4:00 to 5:15 pm 5:00 Innate Immunity Factors from Fungi
Marriott North Tower, Lobby Level, Marriott Hall Salon 5 Anthony A. Horner, MD FAAAAI
Credit: 1.25 CME / 1.50 CE 5:15 Damp Buildings, Respiratory Disease and Asthma
Moderator: Sally A. Noone, RN MSN CCRC Kari E. Reijula, MD PhD FAAAAI
Larry Thompson 5:30 Allergens from Damp Housing
Upon completion of this session, participants should be able to: Identify actions to protect Eva-Maria King, PhD
hardware and software; Describe how to implement security measures to protect a 5:45 Question & Answer
practice; Identify how to set up emergency plans in case of a breach.
Upon completion of this session, participants should be able to: Review the multiple expert
panels/reports and Position Statements concluding that there is adequate evidence for
respiratory health impacts, including new onset asthma, due to damp buildings; Describe
the challenges of quantifying dampness and establishing acceptable moisture levels;
Recognize the several plausible mechanisms that underlie the adverse respiratory impacts
of the damp building effect.
34
Allied Health Session ticket required fee required included in the Virtual Annual Meeting